17-Dec-2025
Insider Stock Sale Stirs Interest in Artivion
TipRanks (Wed, 17-Dec 9:04 PM ET)
Artivion: Strategic Growth, Market Expansion, and Long-Term Value Creation Drive Buy Rating
TipRanks (Wed, 17-Dec 6:55 AM ET)
Artivion Reports Third Quarter 2025 Financial Results
PRNewswire (Thu, 6-Nov 4:06 PM ET)
Artivion to Participate in the Stifel 2025 Healthcare Conference
PRNewswire (Wed, 29-Oct 4:10 PM ET)
PRNewswire (Thu, 23-Oct 4:10 PM ET)
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Artivion trades on the NYSE stock market under the symbol AORT.
As of December 17, 2025, AORT stock price climbed to $47.18 with 648,067 million shares trading.
AORT has a beta of 0.70, meaning it tends to be less sensitive to market movements. AORT has a correlation of 0.08 to the broad based SPY ETF.
AORT has a market cap of $2.24 billion. This is considered a Mid Cap stock.
Last quarter Artivion reported $113 million in Revenue and $.16 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.01.
In the last 3 years, AORT traded as high as $48.25 and as low as $11.39.
The top ETF exchange traded funds that AORT belongs to (by Net Assets): IJR, VTI, IWM, VXF, SPSM.
AORT has outperformed the market in the last year with a price return of +62.9% while the SPY ETF gained +11.8%. AORT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +19.3% and +4.0%, respectively, while the SPY returned +2.0% and -1.5%, respectively.
AORT support price is $45.03 and resistance is $46.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AORT shares will trade within this expected range on the day.